000286602 001__ 286602
000286602 005__ 20240229155127.0
000286602 0247_ $$2doi$$a10.1515/medgen-2023-2049
000286602 0247_ $$2ISSN$$a0936-5931
000286602 0247_ $$2ISSN$$a1863-5490
000286602 037__ $$aDKFZ-2023-02814
000286602 082__ $$a610
000286602 1001_ $$0P:(DE-He78)a7f54298fcba548e34453b02202e6519$$aBohaumilitzky, Lena$$b0$$eFirst author$$udkfz
000286602 245__ $$aLiquid biopsy-based early tumor and minimal residual disease detection : New perspectives for cancer predisposition syndromes
000286602 260__ $$aBerlin$$bde Gruyter$$c2023
000286602 3367_ $$2DRIVER$$aarticle
000286602 3367_ $$2DataCite$$aOutput Types/Journal article
000286602 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1703847334_27806
000286602 3367_ $$2BibTeX$$aARTICLE
000286602 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000286602 3367_ $$00$$2EndNote$$aJournal Article
000286602 500__ $$a#EA:F210#LA:F210#
000286602 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000286602 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000286602 7001_ $$0P:(DE-He78)c826cd3421c6d05725b35568f80b4c67$$aGebert, Johannes$$b1$$udkfz
000286602 7001_ $$0P:(DE-HGF)0$$aDoeberitz, Magnus von Knebel$$b2
000286602 7001_ $$0P:(DE-He78)028ee60cca729028708496826f077b58$$aKloor, Matthias$$b3$$udkfz
000286602 7001_ $$0P:(DE-He78)07eef6d38a91f4642c810745c5bf5000$$aAhadova, Aysel$$b4$$eLast author$$udkfz
000286602 773__ $$0PERI:(DE-600)2163157-8$$a10.1515/medgen-2023-2049$$gVol. 35, no. 4, p. 259 - 268$$n4$$p259 - 268$$tMedizinische Genetik$$v35$$x0936-5931$$y2023
000286602 909CO $$ooai:inrepo02.dkfz.de:286602$$pVDB
000286602 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a7f54298fcba548e34453b02202e6519$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000286602 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c826cd3421c6d05725b35568f80b4c67$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000286602 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000286602 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)028ee60cca729028708496826f077b58$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000286602 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)07eef6d38a91f4642c810745c5bf5000$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000286602 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000286602 9141_ $$y2023
000286602 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-25$$wger
000286602 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
000286602 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
000286602 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
000286602 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-25
000286602 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
000286602 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-25
000286602 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMED GENET-BERLIN : 2022$$d2023-10-25
000286602 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-25
000286602 9202_ $$0I:(DE-He78)F210-20160331$$kF210$$lKKE Angewandte Tumorbiologie$$x0
000286602 9201_ $$0I:(DE-He78)F210-20160331$$kF210$$lKKE Angewandte Tumorbiologie$$x0
000286602 9200_ $$0I:(DE-He78)F210-20160331$$kF210$$lKKE Angewandte Tumorbiologie$$x0
000286602 980__ $$ajournal
000286602 980__ $$aVDB
000286602 980__ $$aI:(DE-He78)F210-20160331
000286602 980__ $$aUNRESTRICTED